Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$59.60
Day range
$60.00 - $61.50
Year range
$35.05 - $82.00
Market cap
14.56B TWD
Avg Volume
300.82K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.81M | -69.08% |
Operating expense | 278.88M | -43.85% |
Net income | -278.21M | 46.29% |
Net profit margin | -9.90K | -73.68% |
Earnings per share | — | — |
EBITDA | -250.18M | 45.99% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 376.96M | -1.00% |
Total assets | 2.74B | -1.02% |
Total liabilities | 1.84B | -5.17% |
Total equity | 893.31M | — |
Shares outstanding | 164.07M | — |
Price to book | 10.96 | — |
Return on assets | -24.23% | — |
Return on capital | -25.99% | — |
Cash Flow
Net change in cash
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -278.21M | 46.29% |
Cash from operations | -284.01M | 32.04% |
Cash from investing | -33.41M | -65.08% |
Cash from financing | -62.37M | -75.47% |
Net change in cash | -365.14M | 25.94% |
Free cash flow | -242.47M | -2.91% |
About
Founded
2013
Website
Employees
133